CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Income Statement
NYSEARCA:CANF - NYSE Arca - US13471N3008 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 674.00K | 743.00K | 810.00K | 853.00K | 763.00K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 8.80M | 8.94M | 10.91M | 13.70M | 14.90M | |||
| Research and Development | 5.76M | 5.98M | 3.15M | 3.85M | 2.95M | |||
| Selling, General, and Administrative Expenses | 3.05M | 2.96M | 7.75M | 9.85M | 11.95M | |||
| Operating Income | -8.13M | -8.20M | -10.10M | -12.84M | -14.14M | |||
| Interest Income/Expense | 264.00K | 575.00K | -61.00K | 245.00K | 82.00K | |||
| Other Income/Expense | -14.00K | -14.00K | -16.00K | -18.00K | -386.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -7.88M | -7.63M | -10.17M | -12.62M | -14.44M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -7.88M | -7.63M | -10.17M | -15.21M | -15.16M | |||
| EBITDA | -8.12M | -8.18M | -10.08M | -12.83M | -14.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.61 | -1.02 | -2.12 | -4.66 | -7.16 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -1169.14% | -1027.46% | -1255.93% | -1782.53% | -1986.63% | |||
| Operating Profit Margin | -1206.23% | -1102.96% | -1246.42% | -1505.51% | -1853.08% | |||
All data in USD